Francesco Cipollone

Francesco Cipollone

Auto-generated profile, based on publicly available information

Francesco Cipollone

Atherosclerosis Prevention Center, G. d'Annunzio University of Chieti, Chieti, Italy

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2003 in Circulation
Verified
Journal Article
Closed access
FCFrancesco Cipollone
Francesco Cipollone
AIAnnalisa Iezzi
Annalisa Iezzi
MFMaria Fazia
Maria Fazia
MZMirco Zucchelli
Mirco Zucchelli
BPBarbara Pini
Barbara Pini
AMAndrea Mezzetti
Andrea Mezzetti
Background— RAGE (receptor for advanced glycation end products [AGEs]) plays a role in diabetic atherosclerosis. Recently, we have demonstrated enhanced expression of cyclooxygenase-2 and PGE synthase-1 (COX-2/mPGES-1) in human symptomatic plaques, and provided evidence that it is associated with metalloproteinase (MMP)-induced plaque rupture. However, the specific transmembrane signaling pathway(s) influencing plaque COX-2/mPGES-1 expression is unknown. The aim of this study was to characterize RAGE expression in human plaques and to correlate it with the inflammatory infiltration, COX-2/mPGES-1 and MMP expression, and with clinical evidence of diabetes. Methods and Results— Plaques obtained from 60 patients undergoing carotid endarterectomy were divided into diabetic and nondiabetic according to clinical evidence of type 2 diabetes. Plaques were subjected to analysis of RAGE, NF-κB, COX-2/mPGES-1, MMP-2 and MMP-9, lipid and oxidized LDL (oxLDL) content, and collagen content by immunohistochemistry and Western blot, whereas zymography was used to detect MMP activity. Immunohistochemistry was used to identify CD68+ macrophages, CD3+ T-lymphocytes, smooth muscle cells (SMCs), and HLA-DR+ inflammatory cells. Diabetic plaques had more ( P <0.0001) macrophages, T-lymphocytes, and HLA-DR+ cells, more ( P <0.0001) immunoreactivity for RAGE, activated NF-κB, COX-2/mPGES-1, and MMPs, increased ( P <0.0001) gelatinolytic activity, reduced ( P <0.0001) collagen content, and increased ( P <0.0001) lipid and oxLDL content. Interestingly, RAGE, COX-2/mPGES-1, and MMP expression was linearly correlated with plasma level of HbA1c. Conclusions— In conclusion, this study demonstrates in humans that RAGE overexpression is associated with enhanced inflammatory reaction and COX-2/mPGES-1 expression in diabetic plaque macrophages, and this effect may contribute to plaque destabilization by inducing culprit metalloproteinase expression.

21 August 2001 in Circulation
Verified
Journal Article
Closed access
PDF file
FCFrancesco Cipollone
Francesco Cipollone
CPCesaria Prontera
Cesaria Prontera
BPBarbara Pini
Barbara Pini
MMMatteo Marini
Matteo Marini
MFMaria Fazia
Maria Fazia
AMAndrea Mezzetti
Andrea Mezzetti
Background — Studies have implicated a role for prostaglandin (PG) E 2 -dependent matrix metalloproteinase (MMP) biosynthesis in the rupture of atherosclerotic plaque. Cyclooxygenase-2 (COX-2) and PGE synthase (PGES) are coregulated in nucleated cells by inflammatory stimuli. The aim of this study was to characterize the expression of COX-2 and PGES in carotid plaques and to correlate it with the extent of inflammatory infiltration and MMP activity and with clinical features of patients’ presentation. Methods and Results — Plaques were obtained from 50 patients undergoing carotid endarterectomy and divided into 2 groups (symptomatic and asymptomatic) according to clinical evidence of recent transient ischemic attack or stroke. Plaques were analyzed for COX-2, PGES, MMP-2, and MMP-9 by immunocytochemistry and Western blot, whereas zymography was used to detect MMP activity. Immunocytochemistry was used to identify CD68+ macrophages, CD3+ T lymphocytes, and HLA-DR+ cells. The percentage of macrophage-rich areas was larger ( P <0.0001) in symptomatic plaques. COX-2, PGES, and MMPs were detected in all specimens; enzyme concentration, however, was significantly higher in symptomatic plaques. COX-2, PGES, and MMPs were especially noted in shoulders of symptomatic plaques, colocalizing with HLA-DR+ macrophages. All symptomatic plaques contained activated forms of MMPs. Finally, inhibition of COX-2 by NS-398 was accompanied by decreased production of MMPs that was reversed by PGE 2 . Conclusions — This study demonstrates the colocalization of COX-2 and PGES in symptomatic lesions and provides evidence that synthesis of COX-2 and PGES by activated macrophages is associated with acute ischemic syndromes, possibly through metalloproteinase-induced plaque rupture.

1 December 1994 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
PPP Patrignani
P Patrignani
MPM R Panara
M R Panara
AGA Greco
A Greco
OFO Fusco
O Fusco
CNClara Natoli
Clara Natoli
JMJ Maclouf
J Maclouf

1 November 1997 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
GDGiovanni Davi
Giovanni Davi
PAPaola Alessandrini
Paola Alessandrini
AMAndrea Mezzetti
Andrea Mezzetti
GMGiorgio Minotti
Giorgio Minotti
TBTonino Bucciarelli
Tonino Bucciarelli
CPCarlo Patrono
Carlo Patrono
F2-isoprostanes are bioactive prostaglandin (PG) -like compounds that are produced from arachidonic acid through a nonenzymatic process of lipid peroxidation catalyzed by oxygen free-radicals. 8-Epi-PGF2αmay amplify the platelet response to agonists, circulates in plasma, and is excreted in urine. We examined the hypothesis that the formation of 8-epi-PGF2αis altered in patients with hypercholesterolemia and contributes to platelet activation in this setting. Urine samples were obtained from 40 hypercholesterolemic patients and 40 age- and sex-matched control subjects for measurement of immunoreactive 8-epi-PGF2α. Urinary excretion of 11-dehydro-thromboxane (TX) B2, a major metabolite of TXA2, was measured as an in vivo index of platelet activation. Low-dose aspirin, indobufen, and vitamin E were used to investigate the mechanism of formation and effects of 8-epi-PGF2αon platelet activation. Urinary 8-epi-PGF2αwas significantly (P=.0001) higher in hypercholesterolemic patients than in control subjects: 473±305 versus 205±95 pg/mg creatinine. Its rate of excretion was inversely related to the vitamin E content of LDL and showed a positive correlation with urinary 11-dehydro-TXB2. Urinary 8-epi-PGF2αwas unchanged after 2-week dosing with aspirin and indobufen despite complete suppression of TX metabolite excretion. Vitamin E supplementation was associated with dose-dependent reductions in both urinary 8-epi-PGF2αand 11-dehydro-TXB2by 34% to 36% and 47% to 58% at 100 and 600 mg daily, respectively. We conclude that the in vivo formation of the F2-isoprostane 8-epi-PGF2αis enhanced in the vast majority of patients with hypercholesterolemia. This provides an aspirin-insensitive mechanism possibly linking lipid peroxidation to amplification of platelet activation in the setting of hypercholesterolemia. Dose-dependent suppression of enhanced 8-epi-PGF2αformation by vitamin E supplementation may contribute to the beneficial effects of antioxidant treatment.

1 February 2012 in Atherosclerosis
Verified
Journal Article
Closed access
Nicola FerriNicola Ferri
Nicola Ferri
GTGianpaolo Tibolla
Gianpaolo Tibolla
APAngela Pirillo
Angela Pirillo
FCFrancesco Cipollone
Francesco Cipollone
AMAndrea Mezzetti
Andrea Mezzetti
Alberico Luigi Catapano‌Alberico Luigi Catapano‌
Alberico Luigi Catapano‌

12 May 2004 in JAMA
Verified
Journal Article
Open access
PDF file
FCFrancesco Cipollone
Francesco Cipollone
Although myocardial infarction (MI) and atherothrombotic ischemic stroke are thought to be caused by rupture of vulnerable atherosclerotic plaques,1 they are recognized to be complex disorders that likely result from multifaceted interactions between an individual's genetic makeup and environmental factors.2,3 Increasing evidence supports a central role for inflammation in the cascade of events that results in plaque fissuring.4,5 Lesion macrophages synthesize matrix metalloproteinases (MMPs); in particular, 72-kDa (MMP-2) and 92-kDa (MMP-9) gelatinase, proteolytic enzymes capable of degrading plaque constituents.6 We recently reported that enhanced MMP-2 and MMP-9 production by macrophages in vulnerable plaques is due to enhancement in prostaglandin E2 (PGE2) synthesis as a result of the induction of COX-2.6-9